Patients
A new kind of treatment. Tailored for every heart.
Every patient’s heart anatomy is unique. Like your fingerprint, no two people have the same heart anatomy.
Overview
If you’re suffering with TR, DUO™ provides an alternative. A minimally invasive option to treat your TR, it’s changing the way people think about the disease.
Tricuspid Regurgitation increases the risk of death.
What are the most common treatment options?
Every heart is unique, including the shape and anatomy of the tricuspid valve. Today, your physician can recommend medications, surgery, or minimally invasive transcatheter treatment options depending on your anatomy. Our TR technology expands your options.
An alternative heart solution for patients.
There is a spectrum of treatment options for Tricuspid Regurgitation. Ask your Doctor to help assess your risk factors and treatment plans to treat advanced TR.
“I believe the DUO System can simplify the treatment of TR patients. With a predictable procedure, performed with standard imaging techniques and minimal anatomic exclusions, it can reach a broad population. It has the potential to emerge as a meaningful advancement in the field of TR treatment”
Martin B. Leon, MD
Mallah Family Professor of Cardiology at the Columbia University Irving Medical Center College of Physicians and Surgeons, Director of the Columbia Center for Interventional Care at New York-Presbyterian Hospital/Columbia University Medical Center
Reach out today to learn more about the groundbreaking new DUO™ System and the clinical trial that is already underway.
"*" indicates required fields
1. Dreyfus F, Flagiello M, Bazire B, et al. Isolated tricuspid surgery: impact of aetiology and clinical presentation on outcomes. European Heart Journal 2020; 41:4304-17.
2. Zack CJ, Fender EA, Chandrashekar P, et al. National trends and outcomes in isoldated tricuspid valve surgery. JACC 2017; 70:2953-60.